Genome sequencing as an alternative to cytogenetic analysis in myeloid cancers

Authors

Eric J. Duncavage, Washington University School of Medicine in St. Louis
Molly C. Schroeder, Washington University School of Medicine in St. Louis
Michele O'Laughlin, Washington University School of Medicine in St. Louis
Roxanne Wilson, Washington University School of Medicine in St. Louis
Sandra MacMillan, Washington University School of Medicine in St. Louis
Andrew Bohannon, Washington University School of Medicine in St. Louis
Scott Kruchowski, Washington University School of Medicine in St. Louis
John Garza, Washington University School of Medicine in St. Louis
Feiyu Du, Washington University School of Medicine in St. Louis
Andrew E.O. Hughes, Washington University School of Medicine in St. Louis
Josh Robinson, Washington University School of Medicine in St. Louis
Emma Hughes, Washington University School of Medicine in St. Louis
Sharon E. Heath, Washington University School of Medicine in St. Louis
Jack D. Baty, Washington University School of Medicine in St. Louis
Julie Neidich, Washington University School of Medicine in St. Louis
Matthew J. Christopher, Washington University School of Medicine in St. Louis
Meagan A. Jacoby, Washington University School of Medicine in St. Louis
Geoffrey L. Uy, Washington University School of Medicine in St. Louis
Robert S. Fulton, Washington University School of Medicine in St. Louis
Christopher A. Miller, Washington University School of Medicine in St. Louis
Jacqueline E. Payton, Washington University School of Medicine in St. Louis
Daniel C. Link, Washington University School of Medicine in St. Louis
Matthew J. Walter, Washington University School of Medicine in St. Louis
Peter Westervelt, Washington University School of Medicine in St. Louis
John F. DiPersio, Washington University School of Medicine in St. Louis
Timothy J. Ley, Washington University School of Medicine in St. Louis
David H. Spencer, Washington University School of Medicine in St. Louis

Journal

New England Journal of Medicine

Publication Date

2021

Volume

384

Issue

10

First Page

924

Last Page

935

Document Type

Open Access Publication

DOI

10.1056/NEJMoa2024534

Rights and Permissions

Duncavage EJ, Schroeder MC, O'Laughlin M, Wilson R, MacMillan S, Bohannon A, Kruchowski S, Garza J, Du F, Hughes AEO, Robinson J, Hughes E, Heath SE, Baty JD, Neidich J, Christopher MJ, Jacoby MA, Uy GL, Fulton RS, Miller CA, Payton JE, Link DC, Walter MJ, Westervelt P, DiPersio JF, Ley TJ, Spencer DH. Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers. N Engl J Med. 2021 Mar 11;384(10):924-935. doi: 10.1056/NEJMoa2024534 Copyright © 2021 Massachusetts Medical Society. All rights reserved.

Recommended Citation

Duncavage, Eric J.; Schroeder, Molly C.; O'Laughlin, Michele; Wilson, Roxanne; MacMillan, Sandra; Bohannon, Andrew; Kruchowski, Scott; Garza, John; Du, Feiyu; Hughes, Andrew E.O.; Robinson, Josh; Hughes, Emma; Heath, Sharon E.; Baty, Jack D.; Neidich, Julie; Christopher, Matthew J.; Jacoby, Meagan A.; Uy, Geoffrey L.; Fulton, Robert S.; Miller, Christopher A.; Payton, Jacqueline E.; Link, Daniel C.; Walter, Matthew J.; Westervelt, Peter; DiPersio, John F.; Ley, Timothy J.; and Spencer, David H., "Genome sequencing as an alternative to cytogenetic analysis in myeloid cancers." New England Journal of Medicine. 384, 10. 924 - 935. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10796